San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming ...

SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, ...

A 12-week, 177-participant trial of Hinge Health’s at-home digital program for chronic pain relief significantly reduced users’ lower back pain, disability and interest in surgery. The study, led by ...

Based in San Francisco, Hinge Health has developed a digital platform that employs artificial intelligence to largely automate the treatment of joint and muscle conditions. The platform is designed to ...

Hinge Health’s s-1 filing seems to shed a light on DarioHealth’s potential opportunity; With Hinge targeting a potential $3-6B IPO valuation with similar growth metrics, Dario’s comparable 32.9% ...

Combined with Hinge Health’s AI-powered exercise therapy program, HingeSelect adds access to high-quality in-person providers for members at up to 50% below PPO rates SAN FRANCISCO--(BUSINESS ...

(RTTNews) - Hinge Health, Inc. (HNGE) on Wednesday announced that its board of directors has authorized a $250 million share repurchase program. "During the first three quarters of 2025, we generated ...

Collaboration Will Promote Best-in-Class Menopause Care for Employers and Members SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health and Midi Health announced a partnership today to address the significant ...

SAN FRANCISCO - Hinge Health, Inc. (NYSE:HNGE) announced on November 10 that its board of directors has authorized a $250 million share repurchase program for its outstanding Class A Common Stock. The ...